Results 231 to 240 of about 22,901 (274)
Some of the next articles are maybe not open access.
Current Opinion in Gastroenterology, 2004
Strides have been made in the past year to identify means of decreasing mortality from esophageal adenocarcinoma. This requires a thorough understanding of the risk factor for its development, Barrett esophagus. This article summarizes the most up-to-date and important advancements involving the epidemiology, screening, pathogenesis, surveillance, and ...
John A, Bonino, Prateek, Sharma
openaire +2 more sources
Strides have been made in the past year to identify means of decreasing mortality from esophageal adenocarcinoma. This requires a thorough understanding of the risk factor for its development, Barrett esophagus. This article summarizes the most up-to-date and important advancements involving the epidemiology, screening, pathogenesis, surveillance, and ...
John A, Bonino, Prateek, Sharma
openaire +2 more sources
Journal of Gastroenterology and Hepatology, 2011
AbstractBarrett's esophagus is an acquired metaplastic abnormality in which the normal stratified squamous epithelium lining of the esophagus is replaced by an intestinal‐like columnar epithelium. While in itself a benign and asymptomatic disorder, the clinical importance of this relatively common condition relates to its role as a precursor lesion to ...
Wayne A, Phillips +4 more
openaire +2 more sources
AbstractBarrett's esophagus is an acquired metaplastic abnormality in which the normal stratified squamous epithelium lining of the esophagus is replaced by an intestinal‐like columnar epithelium. While in itself a benign and asymptomatic disorder, the clinical importance of this relatively common condition relates to its role as a precursor lesion to ...
Wayne A, Phillips +4 more
openaire +2 more sources
Chest Surgery Clinics of North America, 1994
The development of the columnar-lined lower esophagus, or Barrett's disease, is an acquired condition due to reflux of gastric and duodenal contents. The medical treatment of patients with reflux disease and Barrett's esophagus is currently the same as for patients with reflux without Barrett's disease which may indicate more aggressive antireflux ...
M, Pera, V F, Trastek
openaire +2 more sources
The development of the columnar-lined lower esophagus, or Barrett's disease, is an acquired condition due to reflux of gastric and duodenal contents. The medical treatment of patients with reflux disease and Barrett's esophagus is currently the same as for patients with reflux without Barrett's disease which may indicate more aggressive antireflux ...
M, Pera, V F, Trastek
openaire +2 more sources
JAMA, 2022
ImportanceBarrett esophagus is characterized by the replacement of normal esophageal squamous cell epithelium with columnar metaplasia and affects approximately 5% of people in the US and approximately 1% worldwide. Approximately 3% to 5% of patients with Barrett esophagus will be diagnosed with esophageal adenocarcinoma in their lifetime ...
openaire +2 more sources
ImportanceBarrett esophagus is characterized by the replacement of normal esophageal squamous cell epithelium with columnar metaplasia and affects approximately 5% of people in the US and approximately 1% worldwide. Approximately 3% to 5% of patients with Barrett esophagus will be diagnosed with esophageal adenocarcinoma in their lifetime ...
openaire +2 more sources
Barrett’s esophagus and Barrett’s carcinoma
Current Oncology Reports, 2003The alarming rise in the incidence of esophageal adenocarcinomas in the Western world has focused interest on so-called Barrett's esophagus. Barrett's esophagus is characterized by specialized intestinal epithelium replacing the normal squamous epithelium in the distal esophagus and is considered a consequence of long-lasting and severe ...
Burkhard H A, von Rahden +2 more
openaire +2 more sources
Barrett's esophagus: chemoprevention
Gastrointestinal Endoscopy Clinics of North America, 2003The clinical applicability of the experimental data discussed previously remains questionable, and results of clinical studies on chemoprevention in Barrett's esophagus are needed. The utility of selectively targeting acid exposure, ODC, and COX-2 is not clear, and elucidation of that role will be facilitated by a better understanding of the ...
Rhonda F, Souza, Stuart J, Spechler
openaire +2 more sources
Biomarkers in Barrett Esophagus
Mayo Clinic Proceedings, 2001Barrett esophagus is a premalignant condition that may progress to adenocarcinoma. The risk of developing cancer has been estimated to be approximately 1 in 250 patient-years of observation; however, there appear to be subsets of patients at much higher risk. Risk stratification has previously been determined by histological identification of dysplasia.
Krishnadath, K. K. +2 more
openaire +2 more sources
Barrett's esophagus: surgical treatments
Annals of the New York Academy of Sciences, 2011The following on surgical treatments for Barrett's esophagus includes commentaries on the indications for antireflux surgery after medical treatment; the effects of the various procedures on the lower esophageal sphincter; the role of impaired esophageal motility and delayed gastric emptying in the choice of the surgical procedure; indications for ...
Parise P +18 more
openaire +2 more sources
Barrett's esophagus registries
Annals of the New York Academy of Sciences, 2011The following on Barrett's esophagus registries contains commentaries on the data sets to be included, organizational issues, and the demographic, lifestyle, and diagnostic differences between the United States and Europe. The importance of collaborative studies is also discussed.
Gatenby, Piers A. C. +4 more
openaire +3 more sources
Postgraduate Medicine, 1989
PreviewBarrett's esophagus is a premalignant condition that should be suspected in any patient presenting with signs and symptoms of chronic reflux esophagitis. The condition itself is asymptomatic, so a high index of suspicion in patients with reflux symptoms is the key to diagnosis.
S E, Wilson, D, Arnstein
openaire +2 more sources
PreviewBarrett's esophagus is a premalignant condition that should be suspected in any patient presenting with signs and symptoms of chronic reflux esophagitis. The condition itself is asymptomatic, so a high index of suspicion in patients with reflux symptoms is the key to diagnosis.
S E, Wilson, D, Arnstein
openaire +2 more sources